Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Keratosis, Actinic 18Glioblastoma 3Carcinoma, Basal Cell 3Precancerous Conditions 2Gliosarcoma 2Brain Neoplasms 2Basal Cell Nevus Syndrome 2Skull Base Neoplasms 1Neurofibromatoses 1Neoplasms 1Mouth Neoplasms 1Meningioma 1Leukoplakia 1Head and Neck Neoplasms 1Glioma 1Erythroplasia 1Breast Neoplasms 1

Interventions

Imatinib Mesylate 2tipifarnib 1nilotinib 1mirdametinib 1cabozantinib 1binimetinib 1Sunitinib 1Sevoflurane 1Propofol 1Percutaneous Collagen Induction 1Nitrous Oxide 1Lidocaine 1Glycopyrrolate 1Dexmedetomidine 1Aminolevulinic Acid 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Neurofibromatoses × Aminolevulinic Acid × Clear all
NCT01682811 2021-06-18

Phase I Photodynamic Therapy (PDT) for Benign Dermal Neurofibromas (NF1)

Medical College of Wisconsin

Phase 1 Completed
20 enrolled 11 charts
CNS

Neurofibromatoses

Data powered by HemOnc (CC BY 4.0) Colophon âš¡